Skip to main content

Table 10 The follow-up data of cardiac color ultrasound

From: The cardioprotective effects of HTK solution and conventional blood cardioplegia in patients with atrial fibrillation undergoing valvular replacement and Cox maze III procedure

Time

Follow-up cases and follow-up rate (%)

LAD

LVEF (%)

HTK

BC

P

HTK

BC

P

HTK

BC

mean

sd

mean

sd

mean

sd

mean

sd

Discharge

53(100)

53(100)

45.64

7.38

47.81

5.29

0.09

55.13

8.52

54.43

4.52

0.59

3month

49(92.45)

48(90.57)

46.2

7.01

48.06

5.42

0.15

57.63

5.54

55.23

4.25

0.02

6month

45(84.91)

46(86.79)

46.36

6.48

48.76

5.55

0.06

59.13

4.99

57.33

4.21

0.07

12month

41(77.36)

38(71.70)

46.88

6.7

48.87

5.8

0.16

60.07

4.46

58.68

4.33

0.17

18month

35(66.04)

33(62.26)

46.89

6.55

48.85

5.28

0.18

60.86

3.67

59.33

4.01

0.11

24month

32(60.38)

29(54.72)

47.25

6.19

49.03

5.21

0.23

62.78

3.12

61.03

3.87

0.06

  1. Notes Data are presented as numbers (%) or as mean ± SD. LAD Left atrial diameter, LVEF Left ventricular ejection fraction